Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons, leading to muscle weakness, paralysis, and ultimately respiratory failure. The disease is often fatal within 3 to 5 years of diagnosis. Though the prevalence of amyotrophic lateral sclerosis is relatively low, with approximately 2 per 100,000 people affected annually, it continues to pose...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that impacts motor neurons, leading to muscle weakness and paralysis. Despite significant research, treatment options for ALS remain limited. However, emerging therapies are poised to change the treatment landscape, offering hope for better outcomes, especially for early-stage ALS patients. Advances in FDA-Approved...